Showing results (81-90 of 123) with videos related to
Sort By:
Pageof 13
British Journal of Clinical Pharmacology|September 27, 2018
Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis: a clinical pharmacological perspective on a surgical procedureLoek A W de Jong, Fortuné M K Elekonawo, Philip R de Reuver, et al.Diabetes, Obesity & Metabolism|November 25, 2016
Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort studyLotte M Knapen, Roy G P J de Jong, Johanna H M Driessen, et al.BMC Cancer|March 3, 2022
Exposure-response analyses of cabozantinib in patients with metastatic renal cell cancerStefanie D Krens, Nielka P van Erp, Stefanie L Groenland, et al.International Journal of Endocrinology|August 22, 2015
Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II TrialT C Schneider, D de Wit, T P Links, et al.Therapeutic Drug Monitoring|July 21, 2015
The Effect of Tamoxifen Dose Increment in Patients With Impaired CYP2D6 ActivityMarieke E B Welzen, Vincent O Dezentjé, Ron H N van Schaik, et al.Diabetes, Obesity & Metabolism|November 6, 2015
Use of incretin agents and risk of pancreatic cancer: a population-based cohort studyL M Knapen, J van Dalem, Y C Keulemans, et al.BMC Cancer|September 20, 2024
A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocolJetty A M Weijers, Gerald W Verhaegh, G Lassche, et al.BJC Reports|November 8, 2024
High-dose short-term osimertinib treatment is effective in patient-derived metastatic colorectal cancer organoidsKirti K Iyer, Dennis Poel, Anne Miggelenbrink, et al.British Journal of Clinical Pharmacology|November 14, 2014
Integrated semi-physiological pharmacokinetic model for both sunitinib and its active metabolite SU12662Huixin Yu, Neeltje Steeghs, Jacqueline S L Kloth, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2010
Genetic polymorphisms associated with a prolonged progression-free survival in patients with metastatic renal cell cancer treated with sunitinibAstrid A M van der Veldt, Karel Eechoute, Hans Gelderblom, et al.Pageof 13